Quanterix Corporation Accounts Receivable, Allowance for Credit Loss, Recovery
Quanterix Corporation (QTRX) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $73.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Notes › Receivables › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2021-08-05
- Quanterix Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2020 was $493.00K, a 208.12% increase from fiscal 2019.
- Quanterix Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2019 was $160.00K, a 344.44% increase from fiscal 2018.
- Quanterix Corporation accounts receivable, allowance for credit loss, recovery for fiscal 2018 was $36.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|
| 2021-06-30 | $73.00K 10-Q · filed 2021-08-05 | |
| 2020-12-31 | $493.00K 10-K · filed 2021-03-05 | |
| 2019-12-31 | $160.00K 10-K · filed 2021-03-05 | |
| 2018-12-31 | $36.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |